Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study
Both SVR and statin treatment were associated with reduced risk of decompensation in patients with HCV. These findings may inform clinical management to reduce the risk of DC among patients with HCV.
Authors
- Sheri Trudeau (ORCID: https://orcid.org/0000-0003-1280-0833)
- Y. Wang
- Loralee B. Rupp (ORCID: https://orcid.org/0000-0002-2048-5100)
- Yihe G. Daida (ORCID: https://orcid.org/0000-0003-1628-0476)
- M. C. Lu
- Trueman Wu (ORCID: https://orcid.org/0009-0000-8237-0862)
- S C Gordon
- Mark A Schmidt
- Kimberly A Brown
Institutions
- Michigan Department of Health and Human Services (US)
- Kaiser Permanente (US)
- Henry Ford Health System (US)
- Wayne State University (US)
- Kaiser Permanente Center for Health Research (US)
- Michigan State University (US)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-001946
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00